Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 7/20 | 0.93 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.93 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.93 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.93 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.93 |
| ▸ | SRC | P12931 | 2/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.93 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.93 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.93 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.86 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.86 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.86 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.86 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.82 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.79 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.79 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.79 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.79 |
| ▸ | LDHA | P00338 | 1/20 | 0.79 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18089718 | 1.00 | P2RY1 (0.93) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL30066823 | 1.00 | P2RY1 (0.93) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Atpgammas SCHEMBL18089704 | 1.00 | P2RY1 (0.93) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Atpgammas SCHEMBL14942243 | 1.00 | P2RY1 (0.93) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL3096785 | 1.00 | P2RY1 (0.93) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Atpgammas SCHEMBL29381816 | 1.00 | P2RY1 (0.93) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL4357990 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL4069414 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| SCHEMBL21067711 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 | |
| Diadenosine Tetraphosphate SCHEMBL849869 | 0.96 | P2RY1 (1.00) | P2RY1P2RY2P2RX1P2RX3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8309298-B2 | Method for detecting protein | SYSMEX CORPORATION (JP) | 2012-11-13 | — | — | US | claimed |
| US-8247382-B2 | Method for increasing oxytocin release in the epidermis | SHISEIDO COMPANY, LTD. (JP) | 2012-08-21 | — | — | US | claimed |
| US-7960131-B2 | Functional genomic pore assay for mixed cell populations | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-06-14 | — | — | US | claimed |
| US-7754442-B2 | Reagent kit for determining characteristic of tissue | SYSMEX CORPORATION (JP) | 2010-07-13 | — | — | US | claimed |
| US-20100130438-A1 | METHOD FOR INCREASING OXYTOCIN RELEASE IN THE EPIDERMIS | SHISEIDO COMPANY, LTD. (JP) | 2010-05-27 | — | — | US | claimed |
| US-7560243-B2 | White blood cell functional assay | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-07-14 | — | — | US | claimed |
| US-20090053204-A1 | Functional Genomic Pore Assay For Mixed Cell Populations | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-02-26 | — | — | US | claimed |
| EP-1609854-B1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORP (JP) | 2008-04-30 | — | — | EP | claimed |
| US-7338774-B2 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2008-03-04 | — | — | US | claimed |
| US-20080003630-A1 | Tyrosine kinse substrate | SYSMEX CORPORATION (JP) | 2008-01-03 | — | — | US | claimed |
| US-20070264624-A1 | METHOD FOR DETERMINING ACTIVITY OF CELL CYCLE REGULATORY FACTOR AND METHOD FOR DIAGNOSING CANCER USING THE SAME | ISHIHARA HIDEKI | 2007-11-15 | — | — | US | claimed |
| EP-1233060-B1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORP (JP) | 2007-11-14 | — | — | EP | claimed |
| US-20070105177-A1 | Method for detecting analyte in sample, method for quantifying activity of enzyme, and method for quantifying protein in sample | SYSMEX CORPORATION | 2007-05-10 | — | — | US | claimed |
| EP-1767943-A2 | Method for detecting analyte in sample | Sysmex Corporation (JP) | 2007-03-28 | — | — | EP | claimed |
| WO-2007020018-A1 | USE OF PURINERGIC AND PYRIMIDINERGIC RECEPTOR AGONISTS FOR DENDRITIC CELLS BASED IMMUNOTHERAPIES | UNIVERSITE LIBRE DE BRUXELLES (BE) | 2007-02-22 | — | — | WO | claimed |
| EP-1609854-A1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2005-12-28 | — | — | EP | claimed |
| US-20040253650-A1 | White blood cell functional assay | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-12-16 | — | — | US | claimed |
| US-20020164673-A1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2002-11-07 | — | — | US | claimed |
| EP-1233060-A2 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2002-08-21 | — | — | EP | claimed |
| US-20260109980-A1 | RNA-GUIDED DNA INTEGRATION USING TN7-LIKE TRANSPOSONS | UNIV COLUMBIA (US) | 2026-04-23 | — | — | US | disclosed |
| US-12331292-B2 | RNA-guided DNA integration using Tn7-like transposons | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250101425-A1 | NANOPARTICLES FUNCTIONALIZED WITH GENE EDITING TOOLS AND RELATED METHODS | STEMGENICS, INC. (US) | 2025-03-27 | — | — | US | disclosed |
| WO-2024226422-A1 | HELICASE DEGRADERS | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| US-20230203142-A1 | TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A NOVEL CIRCULATING HORMONE COMPLEX | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-06-29 | — | — | US | disclosed |
| EP-3985125-A1 | RECOMBINASE POLYMERASE AMPLIFICATION | Abbott Diagnostics Scarborough, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-112236528-A | Method for producing nano-and micro-arrays | 诺迪勒思生物科技公司 | 2021-01-15 | — | — | CN | disclosed |
| US-9901624-B2 | Methods and compositions for treating nephrogenic diabetes insipidus | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2018-02-27 | — | — | US | disclosed |
| US-20170035859-A1 | METHODS AND COMPOSITIONS FOR TREATING NEPHROGENIC DIABETES INSIPIDUS | KISHORE BELLAMKONDA K (US) | 2017-02-09 | — | — | US | disclosed |
| US-20160304459-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR | TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES (JP) | 2016-10-20 | — | — | US | disclosed |
| US-9393250-B2 | Phthalocyanine compounds useful as RecA inhibitors and methods of using same | UNIVERSITY OF SASKATCHEWAN (CA) | 2016-07-19 | — | — | US | disclosed |
| EP-2045746-B1 | A device for supporting diagnosis of cancer | SYSMEX CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| US-9155792-B2 | RecA inhibitors with antibiotic activity, compositions and methods of use | TRUSTEES OF BOSTON UNIVERSITY (US) | 2015-10-13 | — | — | US | disclosed |
| US-20150276740-A1 | METHOD FOR DETERMINING KINASE ACTIVITY | SYSMEX CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-9146239-B2 | Method of judging risk of cancer recurrence and computer program | SYSMEX CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-9006208-B2 | Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2015-04-14 | — | — | US | disclosed |
| US-20150087612-A1 | PHTHALOCYANINE COMPOUNDS USEFUL AS RECA INHIBITORS AND METHODS OF USING SAME | UNIVERSITY OF SASKATCHEWAN (CA) | 2015-03-26 | — | — | US | disclosed |
| US-20150037351-A1 | NOVEL THERAPEUTIC TARGET FOR THE PREVENTION OF TUMOUR METASTASIS | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2015-02-05 | — | — | US | disclosed |
| EP-2600150-B1 | Method for determining sensitivity of tumor cells to dasatinib and computer program | SYSMEX CORP (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-8921114-B2 | Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program product | SYSMEX CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8921057-B2 | Method of assessing properties of mammalian cells, and method of diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-20130323748-A1 | METHOD OF JUDGING RISK OF CANCER RECURRENCE AND COMPUTER PROGRAM | SYSMEX CORPORATION (JP) | 2013-12-05 | — | — | US | disclosed |
| US-8583588-B2 | Method for judging risk of cancer recurrence, computer program, and computer system | SYSMEX CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-2641969-A1 | Novel therapeutic target for the prevention of tumour metastasis | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-09-25 | — | — | EP | disclosed |
| EP-2371968-B1 | Method for judging risk of cancer recurrence, computer program, and computer system | SYSMEX CORP (JP) | 2013-09-11 | — | — | EP | disclosed |
| EP-2614838-A1 | AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY COMBINING P2Y² RECEPTOR AGONIST WITH HYALURONIC ACID OR SALT THEREOF, METHOD FOR TREATING DRY EYE, AND USE OF THE P2Y² RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF | Santen Pharmaceutical Co., Ltd (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-20130172287-A1 | AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY COMBINING P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF, METHOD FOR TREATING DRY EYE, AND USE OF THE P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2013-07-04 | — | — | US | disclosed |
| US-8476245-B2 | Inhibition of tumor growth and invasion by anti matrix metalloproteinase DNAzymes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-07-02 | — | — | US | disclosed |
| US-20130143236-A1 | METHOD FOR DETERMINING SENSITIVITY OF TUMOR CELLS TO DASATINIB AND COMPUTER PROGRAM | SYSMEX CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| EP-2600150-A2 | Method for determining sensitivity of tumor cells to dasatinib and computer program | Sysmex Corporation (JP) | 2013-06-05 | — | — | EP | disclosed |
| EP-2600267-A2 | Method of judging risk of cancer recurrence and computer program | SYSMEX CORPORATION (JP) | 2013-06-05 | — | — | EP | disclosed |
| US-8440443-B1 | MEK1 polypeptides | MERCK SHARP & DOHME CORP. (US) | 2013-05-14 | — | — | US | disclosed |
| EP-2372362-B1 | Method for judging susceptibility of cancer cells to anthracycline anticancer agent and computer program | SYSMEX CORP (JP) | 2013-03-27 | — | — | EP | disclosed |
| EP-2400033-B1 | Method for determining sensitivity of tumor cells to tyrosine kinase inhibitor and computer program product | SYSMEX CORP (JP) | 2013-02-20 | — | — | EP | disclosed |
| US-8357701-B2 | Galactokinase inhibitors | UNIVERSITY OF MIAMI (US) | 2013-01-22 | — | — | US | disclosed |
| US-8309298-B2 | Method for detecting protein | SYSMEX CORPORATION (JP) | 2012-11-13 | — | — | US | disclosed |
| US-20120278000-A1 | METHOD FOR ASSESSING EFFICACY OF COMBINATION CHEMOTHERAPY, AND PROGRAM AND DEVICE FOR ASSESSING THE SAME | SYSMEX CORPORATION (JP) | 2012-11-01 | — | — | US | disclosed |
| EP-2278025-B1 | METHOD FOR EVALUATION OF DEGREE OF MALIGNANCY OF TUMOR CELL | SYSMEX CORP (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-8247382-B2 | Method for increasing oxytocin release in the epidermis | SHISEIDO COMPANY, LTD. (JP) | 2012-08-21 | — | — | US | disclosed |
| EP-1970453-B1 | Primer, primer set, and nucleic acid amplification method and mutation detection method using the same | RIKEN (JP) | 2012-08-01 | — | — | EP | disclosed |
| US-8160821-B2 | Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugs | SYSMEX CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| EP-1807065-B1 | METHODS AND COMPOSITIONS FOR TREATING NEPHROGENIC DIABETES INSIPIDUS | UNIV UTAH RES FOUND (US) | 2012-03-28 | — | — | EP | disclosed |
| US-8131520-B2 | Cancer diagnostic device | SYSMEX CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8119364-B2 | Methods for generating analogs of coenzyme A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-02-21 | — | — | US | disclosed |
| EP-2410332-A1 | Method for identifying purinergic modulators of the olfactory system | The University Of Utah (US) | 2012-01-25 | — | — | EP | disclosed |
| EP-1624753-B1 | PURINERGIC MODULATION OF SMELL | UNIV UTAH RES FOUND (US) | 2012-01-25 | — | — | EP | disclosed |
| US-20110318768-A1 | METHOD FOR DETERMINING SENSITIVITY OF TUMOR CELLS TO TYROSINE KINASE INHIBITOR AND COMPUTER PROGRAM PRODUCT | SYSMEX CORPORATION (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2400033-A1 | Method for determining sensitivity of tumor cells to tyrosine kinase inhibitor and computer program product | SYSMEX CORPORATION (JP) | 2011-12-28 | — | — | EP | disclosed |
| US-8067162-B2 | Replication; hybridization; kits | RIKEN (JP) | 2011-11-29 | — | — | US | disclosed |
| EP-1427837-B1 | MODULAR TRANSFECTION SYSTEMS BASED ON NUCLEOPROTEIN FILAMENTS | LONZA COLOGNE GMBH (DE) | 2011-10-26 | — | — | EP | disclosed |
| US-8041514-B2 | Method for judging feature of malignant tumor | SYSMEX CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20110251236-A1 | GALACTOKINASE INHIBITORS | UNIVERSITY OF MIAMI (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110246413-A1 | METHOD FOR JUDGING RISK OF CANCER RECURRENCE, COMPUTER PROGRAM, AND COMPUTER SYSTEM | SYSMEX CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110244497-A1 | METHOD FOR JUDGING SUSCEPTIBILITY OF CANCER CELLS TO ANTHRACYCLINE ANTICANCER AGENT AND COMPUTER PROGRAM | SYSMEX CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| EP-2371951-A1 | NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS | Riken (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-2371968-A1 | Method for judging risk of cancer recurrence, computer program, and computer system | Sysmex Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-2372362-A2 | Method for judging susceptibility of cancer cells to anthracycline anticancer agent and computer program | Sysmex Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20110236900-A1 | NOVEL MUTS PROTEIN AND METHOD FOR DETERMING MUTATION USING THE SAME | RIKEN (JP) | 2011-09-29 | — | — | US | disclosed |
| US-8021831-B2 | Determination of cancer cells; analyzing gene expression; cell cycle profile | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-09-20 | — | — | US | disclosed |
| US-8014960-B2 | Method of supporting a diagnosis of a risk of cancer recurrence, and a device of supporting a diagnosis of a risk of cancer recurrence | SYSMEX CORPORATION (JP) | 2011-09-06 | — | — | US | disclosed |
| US-8012720-B2 | Protein detecting device | FUJITSU LIMITED (JP) | 2011-09-06 | — | — | US | disclosed |
| US-8008274-B2 | P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis | INSPIRE PHARMACEUTICALS, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| US-7999073-B2 | Modular transfection systems | LONZA COLOGNE GMBH (DE) | 2011-08-16 | — | — | US | disclosed |
| US-7960131-B2 | Functional genomic pore assay for mixed cell populations | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-06-14 | — | — | US | disclosed |
| US-20110136131-A1 | Method for measuring enzyme activity and column for use in measuring enzyme activity | SYSMEX CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| US-7957910-B2 | Method for predicting effectiveness of chemotherapy | SYSMEX CORPORATION (JP) | 2011-06-07 | — | — | US | disclosed |
| US-20110027809-A1 | METHOD FOR EVALUATION OF DEGREE OF MALIGNANCY OF TUMOR CELL | SYSMEX CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| EP-2278025-A1 | METHOD FOR EVALUATION OF DEGREE OF MALIGNANCY OF TUMOR CELL | Sysmex Corporation (JP) | 2011-01-26 | — | — | EP | disclosed |
| EP-1905840-B1 | Method for assessing proliferation inhibiting effect of inhibitor, and method for screening a compound which inhibits proliferation of a tumor cell | SYSMEX CORP (JP) | 2010-12-22 | — | — | EP | disclosed |
| US-20100304430-A1 | Methods for Generating Analogs of Coenzyme A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-12-02 | — | — | US | disclosed |
| EP-1767647-B1 | METHOD OF JUDGING MALIGNANCY OF A MAMMALIAN CANCER CELL | SYSMEX CORP (JP) | 2010-11-24 | — | — | EP | disclosed |
| US-20100250483-A1 | EFFECT PREDICTING APPARATUS, COMPUTER PROGRAM PRODUCT, AND METHOD FOR PREDICTING AN EFFECT | SYSMEX CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100221787-A1 | ISOTHERMAL AMPLIFICATION METHOD AND DNA POLYMERASE USED IN THE SAME | RIKEN (JP) | 2010-09-02 | — | — | US | disclosed |
| EP-2210941-A1 | ISOTHERMAL AMPLIFICATION METHOD AND DNA POLYMERASE USED IN THE SAME | Riken (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-7754442-B2 | Reagent kit for determining characteristic of tissue | SYSMEX CORPORATION (JP) | 2010-07-13 | — | — | US | disclosed |
| US-20100144060-A1 | Protein detecting device | FUJITSU LIMITED (JP) | 2010-06-10 | — | — | US | disclosed |
| US-7727738-B2 | Methods for generating analogs of coenzyme A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-06-01 | — | — | US | disclosed |
| US-20100130438-A1 | METHOD FOR INCREASING OXYTOCIN RELEASE IN THE EPIDERMIS | SHISEIDO COMPANY, LTD. (JP) | 2010-05-27 | — | — | US | disclosed |
| US-7700346-B2 | Tissue characteristic determination apparatus | SYSMEX CORPORATION (JP) | 2010-04-20 | — | — | US | disclosed |
| US-7682785-B2 | Method for predicting effectiveness of chemotherapy using anticancer agent | SYSMEX CORPORATION (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20100068743-A1 | Method for predicting response of cancer patient to anticancer drug treatment | John Wayne Cancer Institute and Sysmex Corporation | 2010-03-18 | — | — | US | disclosed |
| EP-2163894-A1 | Method for predicting response of cancer patient to anticancer drug treatment | John Wayne Cancer Institute (US) | 2010-03-17 | — | — | EP | disclosed |
| EP-1826568-B1 | Method for judging the risk of recurrence of malignant tumor | SYSMEX CORP (JP) | 2010-02-24 | — | — | EP | disclosed |
| EP-1600513-B1 | METHOD OF EXAMINING A CELL | SYSMEX CORP (JP) | 2010-02-24 | — | — | EP | disclosed |
| US-7662593-B2 | Activation method of protein derived from extremely thermophilic bacterium in nucleic acid amplification reaction and use thereof | AISIN SEIKI KABUSHIKI KAISHA (JP) | 2010-02-16 | — | — | US | disclosed |
| US-20100029597-A1 | RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2010-02-04 | — | — | US | disclosed |
| US-7634362-B2 | Method for judging feature of malignant tumor | SYSMEX CORPORATION (JP) | 2009-12-15 | — | — | US | disclosed |
| US-20090306010-A1 | P1-(2'-DEOXYCYTIDINE 5'-)P4-(URIDINE 5'-)TETRAPHOSPHATE, TETRA-(ALKALI METAL) SALT, FOR TREATING DISORDERS | MERCK SHARP & DOHME CORP. | 2009-12-10 | — | — | US | disclosed |
| US-20090297497-A1 | Methods and compositions for treating nephrogenic diabetes and insipidus | NATIONAL INSTITUTES OF HEALTH | 2009-12-03 | — | — | US | disclosed |
| US-20090264342-A1 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY | TRUSTEES OF BOSTON UNIVERSITY (US) | 2009-10-22 | — | — | US | disclosed |
| US-20090253156-A1 | MASS SPECTROMETRY METHODS FOR MULTIPLEXED QUANTIFICATION OF PROTEIN KINASES AND PHOSPHATASES | PERKINELMER LAS, INC. | 2009-10-08 | — | — | US | disclosed |
| US-20090246787-A1 | METHOD AND APPARATUS FOR DETERMINING CHEMOSENSITIVITY | SYSMEX CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090246809-A1 | METHOD OF SUPPORTING A DIAGNOSIS OF A RISK OF CANCER RECURRENCE, AND A DEVICE OF SUPPORTING A DIAGNOSIS OF A RISK OF CANCER RECURRENCE | SYSMEX CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090248316-A1 | METHOD FOR SUPPORTING A DIAGNOSIS OF AN EFFECT OF A TREATMENT BY USING ANTHRACYCLINE ANTICANCER DRUGS AND A DEVICE FOR SUPPORTING A DIAGNOSIS FOR AN EFFECT OF A TREATMENT BY USING ANTHRACYCLINE ANTICANCER DRUGS | SYSMEX CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090227663-A1 | INHIBITION OF TUMOR GROWTH AND INVASION BY ANTI MATRIX METALLOPROTEINASES DNAZYMES | POURMOTABBED TAYEBEH | 2009-09-10 | — | — | US | disclosed |
| US-20090220516-A1 | Neuroprotection of retinal ganglion cells | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2009-09-03 | — | — | US | disclosed |
| WO-2009023773-A9 | GALACTOKINASE INHIBITORS | UNIV MIAMI (US) | 2009-07-30 | — | — | WO | disclosed |
| US-7560243-B2 | White blood cell functional assay | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-07-14 | — | — | US | disclosed |
| US-7557092-B2 | Purinergic modulation of smell | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1588755-B1 | DEVICE AND METHOD FOR PROTEIN DETECTION | FUJITSU LTD (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-7531525-B2 | P1-(2′-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating cystic fibrosis | INSPIRE PHARMACEUTICALS, INC. (US) | 2009-05-12 | — | — | US | disclosed |
| US-20090105960-A1 | Device for supporting diagnosis of a cancer and a device for predicting an effects of anthracycline anticancer drugs | SYSMEX CORPORATION (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20090098582-A1 | METHOD FOR DETERMINING RISK OF CANCER RELAPSE AND COMPUTER PROGRAM PRODUCT | SYSMEX CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-2045746-A1 | A device for supporting diagnosis of cancer and a device for predicting effects of anthracycline anticancer drugs | Sysmex Corporation (JP) | 2009-04-08 | — | — | EP | disclosed |
| EP-1686377-B1 | Method for predicting effectiveness of chemotherapy | SYSMEX CORP (JP) | 2009-03-25 | — | — | EP | disclosed |
| US-7507788-B2 | Peptides and methods for cell death regulation | RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES (IL) | 2009-03-24 | — | — | US | disclosed |
| US-7501257-B2 | Molecular diagnostic method of a cancer tissue or a cancer cell | SYSMEX CORPORATION (JP) | 2009-03-10 | — | — | US | disclosed |
| EP-2028936-A2 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2009-03-04 | — | — | EP | disclosed |
| US-20090053204-A1 | Functional Genomic Pore Assay For Mixed Cell Populations | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-02-26 | — | — | US | disclosed |
| WO-2009023773-A2 | GALACTOKINASE INHIBITORS | UNIVERSITY OF MIAMI (US) | 2009-02-19 | — | — | WO | disclosed |
| US-20080227104-A1 | Replication; hybridization; kits | RIKEN (JP) | 2008-09-18 | — | — | US | disclosed |
| EP-1970453-A2 | Primer, primer set, and nucleic acid amplification method and mutation detection method using the same | Riken (JP) | 2008-09-17 | — | — | EP | disclosed |
| US-20080220527-A1 | Expression vector comprising nucleotide sequences coding nucleoprotein filaments for improving heterologous gene expression in cells | AMAXA AG (DE) | 2008-09-11 | — | — | US | disclosed |
| WO-2008094507-A2 | NOVEL FUSION COMPOUNDS | CELLICON BIOTECHNOLOGIES, INC. (US) | 2008-08-07 | — | — | WO | disclosed |
| EP-1575986-A4 | PEPTIDES AND METHODS FOR CELL DEATH REGULATION | UNIV ROCKEFELLER (US) | 2008-07-16 | — | — | EP | disclosed |
| EP-1750131-B1 | Method for judging feature of malignant tumor | SYSMEX CORP (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1674584-B1 | Activation method of protein derived from extremely thermophilic bacterium in nucleic acid amplification reaction and use thereof | AISIN SEIKI (JP) | 2008-05-07 | — | — | EP | disclosed |
| EP-1609854-B1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORP (JP) | 2008-04-30 | — | — | EP | disclosed |
| US-20080090254-A1 | Method for assessing proliferation inhibiting effect of inhibitor, and method for determining sensitivity of tumor cell to inhibitor | SYSMEX CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
| EP-1905840-A1 | Method for assessing proliferation inhibiting effect of inhibitor, and method for determining sensitivity of tumor cell to inhibitor | Sysmex Corporation (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-7338774-B2 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2008-03-04 | — | — | US | disclosed |
| US-7338774-B2 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2008-03-04 | — | — | US | disclosed |
| US-20080044921-A1 | Primers used in novel gene amplification method | FUJIFILM CORPORATION | 2008-02-21 | — | — | US | disclosed |
| WO-2008017586-A2 | SPECIAL CARBONYL-BIS IMINO COMPOUNDS FOR TREATING IMMUNE DISEASES | RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONN (DE) | 2008-02-14 | — | — | WO | disclosed |
| US-7320859-B2 | Using nucleoprotein filament complexes to transfer nucleotide sequences into cells; nonviral gene therapy | AMAXA AG (DE) | 2008-01-22 | — | — | US | disclosed |
| EP-1876246-A1 | Self-complementary primers used in LAMP gene amplification method | FUJIFILM Corporation (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-20080003630-A1 | Tyrosine kinse substrate | SYSMEX CORPORATION (JP) | 2008-01-03 | — | — | US | disclosed |
| US-7297686-B2 | Chromium complex with insulin-like activity | HWANG DAVID L | 2007-11-20 | — | — | US | disclosed |
| WO-2007131191-A2 | MASS SPECTROMETRY METHODS FOR MULTIPLEXED QUANTIFICATION OF PROTEIN KINASES AND PHOSPHATASES | PERKINELMER LIFE AND ANALYTICAL SCIENCES (US) | 2007-11-15 | — | — | WO | disclosed |
| US-20070264624-A1 | METHOD FOR DETERMINING ACTIVITY OF CELL CYCLE REGULATORY FACTOR AND METHOD FOR DIAGNOSING CANCER USING THE SAME | ISHIHARA HIDEKI | 2007-11-15 | — | — | US | disclosed |
| US-20070264624-A1 | METHOD FOR DETERMINING ACTIVITY OF CELL CYCLE REGULATORY FACTOR AND METHOD FOR DIAGNOSING CANCER USING THE SAME | ISHIHARA HIDEKI | 2007-11-15 | — | — | US | disclosed |
| EP-1233060-B1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORP (JP) | 2007-11-14 | — | — | EP | disclosed |
| EP-1558626-A4 | TARGET DETECTION SYSTEM HAVING A CONFORMATIONALLY SENSITIVE PROBE COMPRISING A NUCLEIC ACID BASED SIGNAL TRANSDUCER | AHRAM BIOSYSTEMS INC (KR) | 2007-10-31 | — | — | EP | disclosed |
| US-20070238141-A1 | Method for measuring kinase activity | SYSMEX CORPORATION (JP) | 2007-10-11 | — | — | US | disclosed |
| US-20070231837-A1 | Method of Assessing Properties of Mammalian Cells, and Method of Diagnosing Cancer Using the Same | SYSMEX CORPORATION (JP) | 2007-10-04 | — | — | US | disclosed |
| WO-2007097940-A2 | RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2007-08-30 | — | — | WO | disclosed |
| US-20070202555-A1 | Method for judging feature of malignant tumor | SYSMEX CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| EP-1826568-A1 | Method for judging feature of malignant tumor | SYSMEX CORPORATION (JP) | 2007-08-29 | — | — | EP | disclosed |
| WO-2007095187-A2 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY | TRUSTEES OF BOSTON UNIVERSITY (US) | 2007-08-23 | — | — | WO | disclosed |
| US-20070197454-A1 | P1-(2'-DEOXYCYTIDINE 5'-)P4-(URIDINE 5'-)TETRAPHOSPHATE, TETRA-(ALKALI METAL) SALT, FOR TREATING DISORDERS | MERCK SHARP & DOHME LLC | 2007-08-23 | — | — | US | disclosed |
| US-20070141651-A1 | Method for judging feature of malignant tumor | SYSMEX CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20070128683-A1 | Metabolic delivery of coenzyme A analogs | NATIONAL SCIENCE FOUNDATION | 2007-06-07 | — | — | US | disclosed |
| US-7223744-B2 | Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof | INSPIRE PHARMACEUTICALS, INC. (US) | 2007-05-29 | — | — | US | disclosed |
| US-20070105177-A1 | Method for detecting analyte in sample, method for quantifying activity of enzyme, and method for quantifying protein in sample | SYSMEX CORPORATION | 2007-05-10 | — | — | US | disclosed |
| US-20070077658-A1 | Tissue characteristic determination apparatus | SYSMEX CORPORATION | 2007-04-05 | — | — | US | disclosed |
| US-20070077601-A1 | Reagent kit fr determining characteristic of tissue | SYSMEX CORPORATION | 2007-04-05 | — | — | US | disclosed |
| EP-1770170-A1 | Reagent kit for determining characteristic of tissue | Sysmex Corporation (JP) | 2007-04-04 | — | — | EP | disclosed |
| EP-1767943-A2 | Method for detecting analyte in sample | Sysmex Corporation (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1767648-A1 | METHOD FOR MEASURING ENZYME ACTIVITY AND COLUMN FOR USE IN MEASURING ENZYME ACTIVITY | Sysmex Corporation (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1767647-A1 | METHOD OF JUDGING PROPERTIES OF MAMMALIAN CELL AND METHOD OF DIAGNOSING CANCER | Sysmex Corporation (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1764615-A1 | Tissue characteristic determination apparatus | Sysmex Corporation (JP) | 2007-03-21 | — | — | EP | disclosed |
| WO-2007020018-A1 | USE OF PURINERGIC AND PYRIMIDINERGIC RECEPTOR AGONISTS FOR DENDRITIC CELLS BASED IMMUNOTHERAPIES | UNIVERSITE LIBRE DE BRUXELLES (BE) | 2007-02-22 | — | — | WO | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| US-20070031813-A1 | Method of examining cell | SYSMEX CORPORATION (JP) | 2007-02-08 | — | — | US | disclosed |
| EP-1750131-A1 | Method for judging feature of malignant tumor | Sysmex Corporation (JP) | 2007-02-07 | — | — | EP | disclosed |
| US-20070003964-A1 | Method for predicting effectiveness of chemotherapy using anticancer agent | SYSMEX CORPORATION | 2007-01-04 | — | — | US | disclosed |
| WO-2007002139-A2 | NEUROPROTECTION OF RETINAL GANGLION CELLS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-01-04 | — | — | WO | disclosed |
| EP-1739429-A1 | Method for predicting effectiveness of chemotherapy using anticancer agent | SYSMEX CORPORATION (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-20060264398-A1 | Purinergic modulation of smell | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-11-23 | — | — | US | disclosed |
| US-20060252058-A1 | Chip for detection of nucleic acid | KABUSHIKI KAISHA DNAFORM | 2006-11-09 | — | — | US | disclosed |
| US-20060173632-A1 | Method for predicting effectiveness of chemotherapy | SYSMEX CORPORATION | 2006-08-03 | — | — | US | disclosed |
| EP-1686377-A1 | Method for predicting effectiveness of chemotherapy | Sysmex Corporation (JP) | 2006-08-02 | — | — | EP | disclosed |
| US-20060160115-A1 | Activation method of protein derived from extremely thermophilic bacterium in nucleic acid amplification reaction and use thereof | AISIN SEIKI KABUSHIKI KAISHA (JP) | 2006-07-20 | — | — | US | disclosed |
| US-7078391-B2 | Method of treating edematous retinal disorders | INSPIRE PHARMACEUTICALS, INC. (US) | 2006-07-18 | — | — | US | disclosed |
| EP-1674584-A1 | Activation method of protein derived from extremely thermophilic bacterium in nucleic acid amplification reaction and use thereof | Aisin Seiki Kabushiki Kaisha (JP) | 2006-06-28 | — | — | EP | disclosed |
| EP-1664076-A2 | TAXANE CHEMOSENSITIVITY PREDICTION TEST | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20060105984-A1 | Chromium complex with insulin-like activity | HWANG DAVID L | 2006-05-18 | — | — | US | disclosed |
| US-7045617-B2 | Bisbubstrate inhibitors of kinases | MOUNT SINAI SCHOOL OF MEDICINE (US) | 2006-05-16 | — | — | US | disclosed |
| US-20060058229-A1 | Peptides and methods for cell death regulation | THE ROCKEFELLER UNIVERSITY | 2006-03-16 | — | — | US | disclosed |
| US-20060019914-A1 | Inhibition of tumor growth and invasion by anti-matrix metalloproteinase DNAzymes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-01-26 | — | — | US | disclosed |
| US-20060003437-A1 | Target detecting device and target capturer, device and method for molecular adsorption or desorption, and device and method for protein detection | FUJITSU LIMITED (JP) | 2006-01-05 | — | — | US | disclosed |
| US-20060003939-A1 | Peptides and methods for cell death regulation | RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES (IL) | 2006-01-05 | — | — | US | disclosed |
| EP-1609854-A1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-1609854-A1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-1600513-A1 | METHOD OF EXAMINING CELL | Sysmex Corporation (JP) | 2005-11-30 | — | — | EP | disclosed |
| EP-1588755-A1 | TARGET DETECTING DEVICE AND TARGET CAPTURER, MOLECULE ADSORPTION/DESORPTION DEVICE AND MOLECULE ADSOPRTION/DESOPTION METHOD, AND PROTEIN DETECTING DEVICE AND PROTEIN DETECTING METHOD | FUJITSU LIMITED (JP) | 2005-10-26 | — | — | EP | disclosed |
| EP-1575986-A2 | PEPTIDES AND METHODS FOR CELL DEATH REGULATION | The Rockefeller University (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1558626-A1 | TARGET DETECTION SYSTEM HAVING A CONFORMATIONALLY SENSITIVE PROBE COMPRISING A NUCLEIC ACID BASED SIGNAL TRANSDUCER | Ahram Biosystems Inc. (KR) | 2005-08-03 | — | — | EP | disclosed |
| EP-0948650-B1 | METHOD FOR ELIMINATING SPECIFIC SEQUENCES WHEN CONSTRUCTING DNA LIBRARIES | SERONO GENETICS INST SA (FR) | 2005-07-06 | — | — | EP | disclosed |
| US-20050131057-A1 | Taxane chemosensitivity prediction test | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-06-16 | — | — | US | disclosed |
| US-20050123985-A1 | Protein detecting device | FUJITSU LIMITED | 2005-06-09 | — | — | US | disclosed |
| US-20050118603-A1 | Target detection system having a conformationally sensitive probe comprising a nucleic acid based signal transducer | AHRAM BIOSYSTEMS INC. | 2005-06-02 | — | — | US | disclosed |
| US-20050085439-A1 | Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof | MERCK SHARP & DOHME LLC | 2005-04-21 | — | — | US | disclosed |
| WO-2005020794-A2 | TAXANE CHEMOSENSITIVITY PREDICTION TEST | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2005-03-10 | — | — | WO | disclosed |
| US-6861224-B2 | Apparatus for use in the detection of proteins in sample | FUJITSU LIMITED (JP) | 2005-03-01 | — | — | US | disclosed |
| US-6852501-B2 | Methods for determining ATPase activity and uses thereof | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2005-02-08 | — | — | US | disclosed |
| US-20040253650-A1 | White blood cell functional assay | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-12-16 | — | — | US | disclosed |
| US-6818629-B2 | ADMINISTRATION OF A PHARMACEUTICAL FORMULATION COMPRISING A HYDROLYSIS-RESISTANT P2Y RECEPTOR AGONIST TO STIMULATE THE REMOVAL OF PATHOLOGICAL EXTRANEOUS FLUID FROM THE SUBRETINAL AND RETINAL SPACES; DINUCLEOSIDE POLYPHOSPHATE COMPOUND | INSPIRE PHARMACEUTICALS, INC. | 2004-11-16 | — | — | US | disclosed |
| US-20040137622-A1 | Using nucleoprotein filament complexes to transfer nucleotide sequences into cells; nonviral gene therapy | LONZA COLOGNE GMBH (DE) | 2004-07-15 | — | — | US | disclosed |
| EP-0475160-B2 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-20040077585-A1 | Method of treating edematous retinal disorders | MERCK SHARP & DOHME LLC | 2004-04-22 | — | — | US | disclosed |
| WO-2004033476-A1 | TARGET DETECTION SYSTEM HAVING A CONFORMATIONALLY SENSITIVE PROBE COMPRISING A NUCLEIC ACID BASED SIGNAL TRANSDUCER | AHRAM BIOSYSTEMS INC. (KR) | 2004-04-22 | — | — | WO | disclosed |
| EP-1203234-B1 | NEW ATPase ASSAY | BOEHRINGER INGELHEIM CA LTD (CA) | 2004-03-17 | — | — | EP | disclosed |
| US-20030224500-A1 | Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof | OHREN JEFFREY F (US) | 2003-12-04 | — | — | US | disclosed |
| WO-2003095473-A2 | PEPTIDES AND METHODS FOR CELL DEATH REGULATION | THE ROCKERFELLER UNIVERSITY (US) | 2003-11-20 | — | — | WO | disclosed |
| EP-1233060-A3 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030186917-A1 | Method of treating edematous retinal disorders | MERCK SHARP & DOHME CORP. | 2003-10-02 | — | — | US | disclosed |
| US-20030153014-A1 | Compositions and methods for detecting protein modification and enzymatic activity | SHEN LI (US) | 2003-08-14 | — | — | US | disclosed |
| US-20030134310-A1 | Cellular kinase targets and inhibitors, and methods for their use | COMPOUND THERAPEUTICS, INC. | 2003-07-17 | — | — | US | disclosed |
| EP-0946748-B1 | METHOD FOR DETECTION OF MUTATIONS | AMERSHAM BIOSCIENCES AB (SE) | 2003-07-16 | — | — | EP | disclosed |
| WO-2003054180-A1 | MODIFIED MEK1 AND MEK2, CRYSTAL OF A PEPTIDE: LIGAND: COFACTOR COMPLEX CONTAINING SUCH MODIFIED MEK1 OR MEK2, AND METHODS OF USE THEREOF | WARNER-LAMBERT COMPANY LLC (US) | 2003-07-03 | — | — | WO | disclosed |
| EP-1321518-A1 | Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof | WARNER-LAMBERT COMPANY (US) | 2003-06-25 | — | — | EP | disclosed |
| US-20030087296-A1 | Protein detecting device | FUJITSU LIMITED (JP) | 2003-05-08 | — | — | US | disclosed |
| WO-2003028712-A2 | PURINERGIC AND PYRIMIDINERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF ACTIVATED CD4+ T LYMPHOCYTE-MEDIATED IMMUNE DISEASES | UNIVERSITE LIBRE DE BRUXELLES (BE) | 2003-04-10 | — | — | WO | disclosed |
| US-6492181-B1 | COMPLEXING PHOSPHOMOLYBDATE FROM MOLYBDATE AND RADIOLABELLED PHOSPHATE; SCINTILLATION COUNTING | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-12-10 | — | — | US | disclosed |
| JP-2002335997-A | ASSAY OF ACTIVITY OF CELL CYCLE CONTROLLING FACTOR AND METHOD FOR DIAGNOSING CANCER USING THE SAME | SYSMEX CORP | 2002-11-26 | — | — | JP | disclosed |
| US-20020164673-A1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2002-11-07 | — | — | US | disclosed |
| US-20020164673-A1 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | SYSMEX CORPORATION (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-1233060-A2 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2002-08-21 | — | — | EP | disclosed |
| EP-1233060-A2 | Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same | Sysmex Corporation (JP) | 2002-08-21 | — | — | EP | disclosed |
| EP-1224463-A2 | COMPOSITIONS AND METHODS FOR DETECTING PROTEIN MODIFICATION AND ENZYMATIC ACTIVITY | Superarray, Inc. (US) | 2002-07-24 | — | — | EP | disclosed |
| US-20020058275-A1 | Compositions, kits, and methods for effecting adenine nucleotide modulation of DNA mismatch recognition proteins | THOMAS JEFFERSON UNIVERSITY (US) | 2002-05-16 | — | — | US | disclosed |
| EP-1203234-A1 | NEW ATPase ASSAY | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-05-08 | — | — | EP | disclosed |
| EP-1090137-B1 | PRODUCTION OF POLYMERS FROM NUCLEOTIDIC AND/OR NON-NUCLEOTIDIC ELEMENTS USING ENZYMATIC METHODS | LAROVA BIOCHEMIE GMBH (DE) | 2002-04-03 | — | — | EP | disclosed |
| US-20020031820-A1 | Bisbubstrate inhibitors of kinases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-03-14 | — | — | US | disclosed |
| US-6333153-B1 | MODIFYING DUPLEX DNA BY MIXING THE MISMATCH DUPLEX DNA WITH A MUTS HOMOLOG DIMER IN THE PRESENCE OF A BINDING SOLUTION WHICH CONTAINS ADENOSINE TRIPHOSPHATE NUCLEOTIDES AT A CONCENTRATION OF LESS THAN 3 MICROMOLAR | THOMAS JEFFERSON UNIVERSITY | 2001-12-25 | — | — | US | disclosed |
| US-6329177-B1 | PROVIDING PRIMER LIGATING THE 3' END OF THE CARRIER MOLECULE TO THE 5' POSITION OF THE PRIMER WITH RNA LIGASE; THEREBY OBTAINING A LIGATION PRODUCT; DEPROTECTING THE LIGATION PRODUCT BY REMOVING PURINE OR PYRIMIDINE RIBONUCLEOSIDE | LAROVA BIOCHEMIE GMBH (DE) | 2001-12-11 | — | — | US | disclosed |
| WO-2001070770-A2 | BISUBSTRATE INHIBITORS OF KINASES | THE JOHNS HOPKINS UNIVERSITY (US) | 2001-09-27 | — | — | WO | disclosed |
| US-6284463-B1 | DUPLEXING POLYNUCLEOTIDES; BINDING UNPAIRED SINGLE STRANDS WITH PROTEIN; INCUBATING MISMATCH BINDING PROTEIN WITH ACTIVATOR; CANCER DIAGNOSIS | AMERSHAM PHARMACIA BIOTECH AB (SE) | 2001-09-04 | — | — | US | disclosed |
| US-6248530-B1 | ISOLATING PREFERENTIAL NUCLEIC ACIDS IN SAMPLE; INCUBATE PREFERENTIAL NUCLEOTIDE SEQUENCES, METHYLATE, DISSOCIATE HYBRIDIZED NUCLEOTIDE SEQUENCES, DIGEST WITH METHYLATION SENSITIVE ENZYME, RECOVER PREFERENTIAL NUCLEOTIDE SEQUENCES | GENSET, S.A. (FR) | 2001-06-19 | — | — | US | disclosed |
| WO-2001027624-A2 | COMPOSITIONS AND METHODS FOR DETECTING PROTEIN MODIFICATION AND ENZYMATIC ACTIVITY | SUPERARRAY, INC. (US) | 2001-04-19 | — | — | WO | disclosed |
| EP-1090137-A1 | PRODUCTION OF POLYMERS FROM NUCLEOTIDIC AND/OR NON-NUCLEOTIDIC ELEMENTS USING ENZYMATIC METHODS | Larova Biochemie GmbH (DE) | 2001-04-11 | — | — | EP | disclosed |
| WO-2001010413-A2 | PERIODIC STRUCTURES COMPRISING LIPIDS, POLYELECTROLYTES, AND STRUCTURES-INDUCING SOLUBLE OLIGOVALENT LINKERS | IDEA AG (DE) | 2001-02-15 | — | — | WO | disclosed |
| WO-2000079277-A1 | NEW ATPase ASSAY | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-12-28 | — | — | WO | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| US-6114121-A | SCREENING FOR TARGET NUCLEOTIDE SEQUENCES; PREPARING OLIGONUCLEOTIDES, FORMING AN OLIGONUCLEOTIDE-RECA PROTEIN COMPLEX, INCUBATION WITH SAMPLE, LIGATING OLIGONUCLEOTIDE AND TARGET SEQUENCES, DETECTING LABEL | AISIN COSMOS R&D CO., LTD. (JP) | 2000-09-05 | — | — | US | disclosed |
| WO-1999067413-A1 | PRODUCTION OF POLYMERS FROM NUCLEOTIDIC AND/OR NON-NUCLEOTIDIC ELEMENTS USING ENZYMATIC METHODS | LAROVA BIOCHEMIE GMBH (DE) | 1999-12-29 | — | — | WO | disclosed |
| EP-0948650-A1 | METHOD FOR ELIMINATING SPECIFIC SEQUENCES WHEN CONSTRUCTING DNA LIBRARIES | Serono Genetics Institute S.A. (FR) | 1999-10-13 | — | — | EP | disclosed |
| US-5958696-A | Quantitative solid phase helicase assay | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1999010369-A9 | COMPOSITIONS, KITS, AND METHODS FOR EFFECTING ADENINE NUCLEOTIDE MODULATION OF DNA MISMATCH RECOGNITION PROTEINS | UNIV JEFFERSON (US) | 1999-05-20 | — | — | WO | disclosed |
| WO-1999010369-A1 | COMPOSITIONS, KITS, AND METHODS FOR EFFECTING ADENINE NUCLEOTIDE MODULATION OF DNA MISMATCH RECOGNITION PROTEINS | THOMAS JEFFERSON UNIVERSITY (US) | 1999-03-04 | — | — | WO | disclosed |
| US-5817641-A | Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives | THOMAS JEFFERSON UNIVERSITY (US) | 1998-10-06 | — | — | US | disclosed |
| WO-1998028439-A1 | METHOD FOR ELIMINATING SPECIFIC SEQUENCES WHEN CONSTRUCTING DNA LIBRARIES | GENSET (FR) | 1998-07-02 | — | — | WO | disclosed |
| US-5670628-A | Radio-labelling of proteins | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1997-09-23 | — | — | US | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| WO-1996003134-A1 | TREATMENT OF DIARRHEA WITH 2-SUBSTITUTED ADENOSINE DERIVATIVES | THOMAS JEFFERSON UNIVERSITY (US) | 1996-02-08 | — | — | WO | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| US-4981957-A | VIRICIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1991-01-01 | — | — | US | disclosed |
| US-4981957-A | VIRICIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1991-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077585-A1 | Method of treating edematous retinal disorders | P2RY1, P2RY11, P2RY2 | P2RY1 1/4885P2RY2 3/4885P2RX1 13/4885 |
| US-20150087612-A1 | PHTHALOCYANINE COMPOUNDS USEFUL AS RECA INHIBITORS AND METHODS OF USING SAME | XPA, ERCC4, ERCC2 | P2RY1 621/4885P2RY2 1216/4885P2RX1 874/4885 |
| US-20090264342-A1 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY | ATF1, ATF4, STING1 | P2RY1 530/4885P2RY2 897/4885P2RX1 441/4885 |
| US-20100029597-A1 | RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE | XPA, WRN, BLM | P2RY1 641/4885P2RY2 1246/4885P2RX1 639/4885 |
| US-20110251236-A1 | GALACTOKINASE INHIBITORS | GALK1, GALE, GALC | P2RY1 4264/4885P2RY2 4303/4885P2RX1 4720/4885 |
| US-20080227104-A1 | Replication; hybridization; kits | PCNA, POLL, RNGTT | P2RY1 3481/4885P2RY2 3919/4885P2RX1 3241/4885 |
| US-20130172287-A1 | AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY COMBINING P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF, METHOD FOR TREATING DRY EYE, AND USE OF THE P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF | P2RY2, P2RY12, P2RY13 | P2RY1 5/4885P2RY2 1/4885P2RX1 20/4885 |
| US-20050085439-A1 | Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof | P2RY1, P2RY11, P2RY6 | P2RY1 1/4885P2RY2 4/4885P2RX1 13/4885 |
| US-20260109980-A1 | RNA-GUIDED DNA INTEGRATION USING TN7-LIKE TRANSPOSONS | ZFR, LUC7L2, SLIRP | P2RY1 4387/4885P2RY2 4375/4885P2RX1 4309/4885 |
| US-20030186917-A1 | Method of treating edematous retinal disorders | P2RY1, P2RY11, P2RY2 | P2RY1 1/4885P2RY2 3/4885P2RX1 13/4885 |
| US-20160304459-A1 | NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR | VIP, MRPL21, THEM6 | P2RY1 4785/4885P2RY2 4845/4885P2RX1 4756/4885 |
| US-20060264398-A1 | Purinergic modulation of smell | P2RX5, P2RX3, P2RX6 | P2RY1 37/4885P2RY2 36/4885P2RX1 20/4885 |
| US-20070197454-A1 | P1-(2'-DEOXYCYTIDINE 5'-)P4-(URIDINE 5'-)TETRAPHOSPHATE, TETRA-(ALKALI METAL) SALT, FOR TREATING DISORDERS | P2RY1, P2RY4, P2RY6 | P2RY1 1/4885P2RY2 4/4885P2RX1 6/4885 |
| US-20090306010-A1 | P1-(2'-DEOXYCYTIDINE 5'-)P4-(URIDINE 5'-)TETRAPHOSPHATE, TETRA-(ALKALI METAL) SALT, FOR TREATING DISORDERS | P2RY1, P2RY4, P2RY2 | P2RY1 1/4885P2RY2 3/4885P2RX1 8/4885 |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | P2RY1 3169/4885P2RY2 3062/4885P2RX1 3274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.